Avadel Pharmaceuticals (AVDL) Change in Account Payables: 2015-2022
Historic Change in Account Payables for Avadel Pharmaceuticals (AVDL) over the last 8 years, with Dec 2022 value amounting to $8.5 million.
- Avadel Pharmaceuticals' Change in Account Payables rose 92.22% to $8.5 million in Q4 2022 from the same period last year, while for Dec 2022 it was -$3.1 million, marking a year-over-year decrease of 173.44%. This contributed to the annual value of -$4.1 million for FY2024, which is 364.92% down from last year.
- Avadel Pharmaceuticals' Change in Account Payables amounted to $8.5 million in Q4 2022, which was up 218.81% from -$7.2 million recorded in Q3 2022.
- Over the past 5 years, Avadel Pharmaceuticals' Change in Account Payables peaked at $8.5 million during Q4 2022, and registered a low of -$7.2 million during Q3 2022.
- In the last 3 years, Avadel Pharmaceuticals' Change in Account Payables had a median value of -$370,000 in 2020 and averaged -$138,667.
- Its Change in Account Payables has fluctuated over the past 5 years, first plummeted by 2,935.41% in 2018, then skyrocketed by 1,192.29% in 2021.
- Avadel Pharmaceuticals' Change in Account Payables (Quarterly) stood at -$6.3 million in 2018, then surged by 169.07% to $4.4 million in 2019, then slumped by 71.18% to $1.3 million in 2020, then soared by 250.99% to $4.4 million in 2021, then soared by 92.22% to $8.5 million in 2022.
- Its Change in Account Payables stands at $8.5 million for Q4 2022, versus -$7.2 million for Q3 2022 and $1.2 million for Q2 2022.